Shenzhen Qinglan Biotechnology Co., Ltd. is a high-tech R&D-driven enterprise focusing on soluble microneedle drug delivery, providing a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world.
Jiang Lin, the founder of the company, is the Doctor of Organic Chemistry from Chinese Academy of Sciences, and the leader in the research and development of transdermal drug delivery technology and industrialization of soluble microneedle. He has obtained more than 40 national patents for inventions. The core R&D personnel of the team of Dr. Jiang Lin are composed of doctors and masters with medical, pharmaceutical, and chemical backgrounds, they have been committed to the research of microneedle transdermal drug delivery, take the lead in realizing the research and development and production of microneedle for innovative drugs.
BIOQINGLAM, which has been established less than three years ago, has completed two rounds of financing and is currently conducting A round of financing. The company has cooperated with several well-known pharmaceutical companies, and in 2022, the company signed the first microneedle CRO contract in China. At present, many companies are negotiating microneedle business cooperation with BIOQINGLAM, and we are expected to achieve the first IND of microneedle drugs in the next two years.
As a leader in dissolvable microneedle technology, BIOQINGLAM is committed to providing customers with multi-faceted, customized, differentiated services and drug delivery solutions for dissolvable microneedle drug delivery CRO, CMO, and CDMO services to meet the needs of our pharmaceutical partners from preclinical process development to the end of commercial production.
"It starts small."
BIOQINGLAM will be the leader in the field of microneedle drug delivery.